Officials for J&J announced the FDA’s decision during a company conference call after the company released its first quarter results, according to the report. The FDA sent the company a “Not Approvable” letter, along with suggestions the company could consider for the product.
J&J is appealing the FDA’s decision. The anesthesia system is made by J&J Ethicon EndoSurgery division and is approved for use in the European Union for upper GI procedures and colonoscopy and for colonoscopy in Canada, according to the report.
Read the AP’s report on the FDA’s rejection of J&J’s computer-assisted anesthesia device.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
